FDA Fines American Red Cross $4.2M for Blood Safety Lapses September 25, 2006
The Food & Drug Administration has fined the American Red Cross $4.2 million for failure to meet established blood safety requirements for collection of blood products. The ARC acknowledged that it had received an adverse determination letter from the FDA and said in a September 8 statement it will respond to agency concerns within 20 days.
September 25, 2006 - Table of Contents
Archives